Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Biochemistry 33: 3532-3539, 1994
Lixisenatide In patients with mild and moderate renal impairment no dose adjustment is required but close monitoring for lixisenatide related adverse reactions and for changes in renal function is recommended because of higher incidences of hypoglycemia, nausea and vomiting that were observed in these patients
We saw an opportunity to create new value in the GLP-1 space through the combination of addressing access, affordability, clinical safety and long-term lifestyle changes, Cigna COO Brian Evanko said on the call
Phelps NH, Singleton RK, Zhou B, Al
US$ 20.82
US$ 26.67
US$ 26.60
US$ 22.18
